Autoimmune lymphoproliferative syndrome type III: an indefinite disorder

Leukemia & Lymphoma
J van der Werff ten BoschK Thielemans

Abstract

Autoimmune Lymphoproliferative Syndrome (ALPS) is a childhood disorder characterized by chronic nonmalignant lymphoproliferation and autoimmunity. Although the pathogenesis is not fully understood, deficient Fas mediated apoptosis appears to be an important factor. This deficiency can be caused by a mutation of the APT1 gene (ALPS type Ia), of the FasL gene (ALPS type Ib), or of the Caspase-10 gene (ALPS type II). In one sub population of patients, no mutations have been identified as yet (ALPS type III). According to published data, the latter group is much smaller than the group of patients with ALPS type Ia. However, because of the variability of the clinical presentation and the absence of a known genetic defect, this disease is difficult to diagnose, the more so as few data have been reported on these patients. Thus, ALPS type III could be more common than believed until now. In this review we provide evidence for this hypothesis.

References

Aug 1, 1992·The Journal of Clinical Investigation·M C SnellerW Strober
Jun 1, 1967·The Journal of Pediatrics·V C Canale, C H Smith
Mar 1, 1994·The Journal of Clinical Investigation·E MyslerK B Elkon
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·C G TepperM F Seldin
Jan 26, 1996·The Journal of Biological Chemistry·J SchlegelD W Nicholson
Apr 26, 1996·The Journal of Biological Chemistry·W Meikrantz, R Schlegel
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·T Fernandes-AlnemriE S Alnemri
Sep 1, 1996·The Journal of Clinical Investigation·J WuJ D Mountz
Dec 1, 1995·Arthritis and Rheumatism·N GoelM F Seldin
Jan 1, 1997·Immunology Today·G KroemerS A Susin
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·L H Boise, C B Thompson
Jul 10, 1997·Nature·M IrmlerJ Tschopp
Jan 7, 1998·The Journal of Experimental Medicine·B WongY Choi
Mar 21, 1998·The Journal of Clinical Investigation·S VidalA N Theofilopoulos
Mar 21, 1998·The Journal of Experimental Medicine·B CombadièreM J Lenardo
Apr 9, 1998·International Immunology·Y KasaharaN Taniguchi
Aug 4, 1998·European Journal of Biochemistry·K Schulze-OsthoffM E Peter
Aug 29, 1998·Bone Marrow Transplantation·B J SleightC L Sidman
Oct 9, 1998·The Journal of Biological Chemistry·H R StennickeG S Salvesen
Nov 12, 1998·The American Journal of Pathology·M S LimE S Jaffe
Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·T S ZhengR A Flavell
Feb 2, 1999·The Journal of Clinical Investigation·A K VaishnawK B Elkon
Mar 26, 1999·American Journal of Human Genetics·C E JacksonJ M Puck
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·D A MartinM J Lenardo
Oct 16, 1999·British Journal of Haematology·J van der Werff ten BoschK Thielemans
Dec 11, 1999·Current Opinion in Pediatrics·C E Jackson, J M Puck
Jan 6, 2000·The Journal of Experimental Medicine·H KörnerM J Smyth

❮ Previous
Next ❯

Citations

Mar 9, 2006·Hematology·V Koneti Rao, Stephen E Straus
Oct 18, 2005·Current Opinion in Immunology·Ismo UlmanenLeena Peltonen
Mar 1, 2003·Paediatric Drugs·Jutte van der Werff ten Bosch
Apr 23, 2008·Current Protocols in Protein Science·Jean-Bernard Denault, Guy S Salvesen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis